Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Elizabeth Ortíz-Sanchez"'
Autor:
Nimsi Campos-Xolalpa, Ángel Josabad Alonso-Castro, Elizabeth Ortíz-Sanchez, Juan Ramon Zapata-Morales, Marco Martin González-Chávez, Salud Pérez
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Drugs used for the treatment of diseases associated with chronic inflammation, such as cancer and rheumatoid arthritis have the potential to cause undesirable side-effects, which might result in patients ending treatment premature
Externí odkaz:
https://doaj.org/article/c8f0691117bf46b39f7f332c22a8479f
Autor:
Manuel Joaquín Romero-López, Hilda Jiménez-Wences, Merlin Itsel Cruz-De La Rosa, Judit Alarcón-Millán, Miguel Ángel Mendoza-Catalán, Elizabeth Ortiz-Sánchez, José Manuel Tinajero-Rodríguez, Daniel Hernández-Sotelo, Gladys Wendy Valente-Niño, Dinorah Nashely Martínez-Carrillo, Gloria Fernández-Tilapa
Publikováno v:
Non-coding RNA Research, Vol 9, Iss 3, Pp 720-731 (2024)
Background: In cervical cancer (CC), miR-218-5p, -124-3p, and −23b-3p act as tumor suppressors. These miRNAs have specific and common target genes that modulate apoptosis, proliferation, invasion, and migration; biological processes involved in can
Externí odkaz:
https://doaj.org/article/a4f1054d7b23449e99ed1ff9289a6f03
Autor:
Karen Griselda De la Cruz-López, Eduardo Alvarado-Ortiz, Heriberto A. Valencia-González, Fredy Omar Beltrán-Anaya, José María Zamora-Fuentes, Alfredo Hidalgo-Miranda, Elizabeth Ortiz-Sánchez, Jesús Espinal-Enríquez, Alejandro García-Carrancá
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-15 (2024)
Abstract Background Metformin, a widely prescribed antidiabetic drug, has shown several promising effects for cancer treatment. These effects have been shown to be mediated by dual modulation of the AMPK-mTORC1 axis, where AMPK acts upstream of mTORC
Externí odkaz:
https://doaj.org/article/f661298270d248fa9adb68a74b521d03
Autor:
Lizbeth Ramírez-Vidal, Jared Becerril-Rico, Alberto Monroy-Mora, Jose Manuel Tinajero-Rodríguez, Federico Centeno-Cruz, Luis F. Oñate-Ocaña, Elizabeth Ortiz-Sánchez
Publikováno v:
Diagnostics, Vol 14, Iss 15, p 1614 (2024)
Gastric cancer (GC) is a leading cause of death, and this pathology often receives a diagnosis in an advanced stage. The development of a less invasive and cost-effective test for detection is essential for decreasing the mortality rate and increasin
Externí odkaz:
https://doaj.org/article/179ce5d2a0f647bc8538660bc990d8ef
Autor:
Jared Becerril-Rico, Julian Grandvallet-Contreras, M. Patricia Ruíz-León, Sebastián Dorantes-Cano, Lizbeth Ramírez-Vidal, José M. Tinajero-Rodríguez, Elizabeth Ortiz-Sánchez
Publikováno v:
Stem Cells International, Vol 2024 (2024)
Gastric cancer (GC) is the fourth leading cause of cancer-related death, associated with late diagnosis and treatment resistance. Currently, screening tests for GC are not cost-effective or have low accuracy. Previously, we described an extended phen
Externí odkaz:
https://doaj.org/article/e445d26334654ff5a2372b9da9dbc7cd
Autor:
Angel A. Gómez-Gallegos, Lizbeth Ramírez-Vidal, Jared Becerril-Rico, Elizabeth Pérez-Islas, Zuly J. Hernandez-Peralta, Mariel E. Toledo-Guzmán, Alejandro García-Carrancá, Elizabeth Langley, Angélica Hernández-Guerrero, Fernando López-Casillas, Roberto Herrera-Goepfert, Luis F. Oñate-Ocaña, Elizabeth Ortiz-Sánchez
Publikováno v:
Stem Cell Research & Therapy, Vol 14, Iss 1, Pp 1-16 (2023)
Abstract Background Gastric cancer (GC) is a leading cause of cancer-related deaths worldwide. Specific and thorough identification of cancer cell subsets with higher tumorigenicity and chemoresistance, such as cancer stem cells (CSCs), could lead to
Externí odkaz:
https://doaj.org/article/6995b97d596740988b891aa41ff51f84
Publikováno v:
Frontiers in Genetics, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/6a9714582462452db6ad38e639041141
Autor:
Jared Becerril-Rico, Eduardo Alvarado-Ortiz, Mariel E. Toledo-Guzmán, Rosana Pelayo, Elizabeth Ortiz-Sánchez
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-14 (2021)
Abstract Cross talk between cancer cells and the immune system is determinant for cancer progression. Emerging evidence demonstrates that GC characteristics such as metastasis, treatment resistance, and disease recurrence are associated with a tumor
Externí odkaz:
https://doaj.org/article/45adf53ee98c4d489ef62bdd114ecc1e
Autor:
Bernardo Cacho-Díaz, Donovan R. García-Botello, Talia Wegman-Ostrosky, Gervith Reyes-Soto, Elizabeth Ortiz-Sánchez, Luis Alonso Herrera-Montalvo
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-12 (2020)
Abstract The present review aimed to discuss contemporary scientific literature involving differences between the tumor microenvironment (TME) in melanoma, lung cancer, and breast cancer in their primary site and TME in brain metastases (BM). TME pla
Externí odkaz:
https://doaj.org/article/71045728ba9f423c885d7e356ef109a6
Autor:
Eduardo Alvarado-Ortiz, Karen Griselda de la Cruz-López, Jared Becerril-Rico, Miguel Angel Sarabia-Sánchez, Elizabeth Ortiz-Sánchez, Alejandro García-Carrancá
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 8 (2021)
Frequent p53 mutations (mutp53) not only abolish tumor suppressor capacities but confer various gain-of-function (GOF) activities that impacts molecules and pathways now regarded as central for tumor development and progression. Although the complete
Externí odkaz:
https://doaj.org/article/15ee4a5b764d43f6943dee031bd2eff4